- Home
- SKYH vs MIST Comparison
SKYH vs MIST Comparison
Compare SKYH & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SKYH | MIST |
|---|---|---|
| Founded | 2017 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 327.2M | 136.9M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | SKYH | MIST |
|---|---|---|
| Price | $10.34 | $1.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $13.13 | $8.00 |
| AVG Volume (30 Days) | 183.4K | ★ 1.6M |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 105.11 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $27,540,000.00 | N/A |
| Revenue This Year | $78.89 | $2,915.14 |
| Revenue Next Year | $73.15 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 86.57 | N/A |
| 52 Week Low | $8.22 | $1.00 |
| 52 Week High | $11.70 | $3.06 |
Technical Indicators
Market Signals| Indicator | SKYH | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 47.10 | 38.79 |
| Support Level | $10.25 | $1.01 |
| Resistance Level | $10.41 | $1.42 |
| Average True Range (ATR) | 0.41 | 0.07 |
| MACD | -0.12 | -0.01 |
| Stochastic Oscillator | 20.76 | 7.37 |
Price Performance
Historical ComparisonAbout SKYH Sky Harbour Group Corporation
Sky Harbour Group Corp is an aviation infrastructure company focused on building the first nationwide network of Home Base Operator (HBO) campuses designed exclusively for business aircraft. The company develops, leases, and manages general aviation hangars across the United States, targeting airfields in markets with aircraft populations and high hangar demand. Its HBS campuses include private hangars and offer a range of services tailored to aircraft owners operating from these facilities. The majority of the company's revenue is derived from the leasing of home-based aircraft hangars and through services and products ancillary to its leasing activities.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.